Medplus Health Services Limited — Others, 14-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

MedPlus Health Services Limited has reported the Monitoring Agency Report from Axis Bank regarding the utilization of proceeds from its Initial Public Offer (IPO) for the quarter ended September 30, 2024. The report indicates that there were no deviations from the intended utilization of funds, with a total net proceed of ₹5,782.73 million. As of the end of the quarter, ₹4,671.70 million was allocated to a subsidiary and ₹448.53 million for general corporate purposes, leaving ₹662.50 million unutilized. This assurance of proper fund utilization could foster a positive outlook among investors by reaffirming financial discipline and operational transparency.